The Pennsylvania Biotechnology Center is the home for the Hepatitis B Foundation and The Baruch S. Blumberg Institute, fostering a collaborative environment for early-stage life science companies to thrive and contribute to the mission of curing Hepatitis B and Liver Cancer. The Hepatitis B Foundation is the global leader in public health, policy and advocacy to eliminate hepatitis B and liver cancer. The Baruch S. Blumberg Institute is a research organization dedicated to finding a cure for hepatitis B and liver cancer.
The Pennsylvania Biotechnology Center (PABC) is a nonprofit life sciences incubator dedicated to the creation of a world-class biotechnology center; to the promotion of regional economic development and job creation; and to the education and training of tomorrow’s researchers.
Managed by the Baruch S. Blumberg Institute, the PABC seeks to advance biotechnology in Bucks County and the surrounding region, maximize synergies between nonprofit scientists and their commercial colleagues, and launch new ideas and discoveries that will make a difference.
Our three organizations are dedicated to upholding evidence-based scientific discovery in a collaborative environment that prioritizes integrity, teamwork, equity, respect, and inclusion of all community members.
The PABC grew significantly in 2022 with the opening of a new 37,000 square foot building on the Doylestown campus and the launch of B+labs at Cira Centre in University City, Philadelphia. The latter is a partnership with Brandywine Realty Trust.
The Center is truly unique with its wealth of resources and core group of nonprofit scientists and educators motivated to work collaboratively with their commercial colleagues on common research themes.
The Pennsylvania Biotechnology Center of Bucks County is managed by the Baruch S. Blumberg Institute.
“Happy to Be Here: An investment that continues to grow” – Bucks County Herald – April 11, 2024
In 2001, former Pennsylvania Gov. Mark Schweiker awarded $7.9 million to the Hepatitis B Foundation toward the development of a biotechnology center in Bucks County, the first of its kind. As his last official act in office, the state award represented an enormous opportunity to stimulate the biotechnology community, fostering an environment where new companies and ideas can develop, and relationships built.
The project initially included the purchase of an empty 62,000 square foot warehouse. The building, which once employed more than 100 workers, was renovated to create state-of-the-art research labs and offices to house nonprofit research organizations and biotech companies under one roof. By using an existing structure, the need for new construction was avoided and spared almost 10 acres of open space from further development. Over the years, two more buildings were purchased on site for a total of 110,00 square feet.
President and Chief Executive Officer
Vice President, Finance
Chief Communications Officer
Chief Development Officer
Chief Operating Officer
Loren Danzis, Esq. – Chair
Elizabeth “Betsy” Seeber, MBA, CPA, FHFMA – Treasurer
Joel Rosen, Esq. – Secretary
Timothy M. Block, PhD
Louis P. Kassa, MPA
Mark Petty
B+labs at Cira Centre is positioned to be the hub of life science entrepreneurial and growth activity in Philadelphia. Located in the Schuylkill Yards neighborhood adjacent to Amtrak’s 30th Street Station, B+labs is a partnership between Brandywine Realty Trust and the Pennsylvania Biotechnology Center (PABC). Brandywine chose PABC to manage the Philadelphia incubator, which opened for business in January 2022.
Current B+labs resident companies, along with their founders, investors, and collaborators, are working with emerging and proven therapeutic modalities to change clinical treatment paradigms and outcomes for patients around the world. B+labs supports these companies with lab space, operational capabilities, and a network of organizations and individuals with expertise across the lifecycle of growth and product development to ensure Philadelphia remains at the frontier of medical innovation. Learn more here.